Abstract
Mefloquine (Fig. 1) is a quinolinemethanol blood schizontocide which is highly effective against drug-resistant as well as drug-sensitive P. falciparum and P. vivax, has a high therapeutic index, and has been accepted for clinical use. The mode and mechanism of mefloquine action are unknown, but available information suggests that cell membranes, internal as well as external, may be selective targets. A general review of mefloquine has recently been written by Sweeney (1981), and the development of mefloquine has been recounted by Schmidt et al. (1978a), and by Canfield and Rozman (1974), all of whom have been instrumental in this process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allison RG, Hahn FE (1977) Changes in superhelical density of closed circular deoxyribonucleic acid by intercalation of anti-R-plasmid drugs and primaquine. Antimicrob Agents Chemother 11: 251–257
Allison JL, O’Brien RL, Hahn FE (1965) DNA: reaction with chloroquine. Science 149: 1111–1113
Brockelman CR, Monkolkeha S, Tanariya P (1981) Decrease in susceptibility of Plasmodium falci¬parum to mefloquine in continuous culture. Bull WHO 59: 249–252
Brown RE, Stancato FA, Wolfe AD (1979 a) The effects of mefloquine on Escherichia coli. Life Sci 25: 1857–1864
Brown RE, Stancato FA, Wolfe AD (1979b) Mefloquine: evidence for a mode of action. Abstracts, No 440, 11th Int Congr Chemother Boston, Mass
Brown RE, Stancato FA, Wolfe AD (1980) Mefloquine: evidence for a mode of action. Curr Chemother Infect Dis Proc 11th Int Congr Chemother, 19th Intersci Conf Antimicrob Agents Chemother 11: 1101–1103
Canfield CJ (1980) Antimalarial alternatives to mefloquine. Acta Trop 37: 232–237
Canfield CJ, Rozman RS (1974) Clinical testing of new antimalarial compounds. Bull WHO 50: 203–212
Carroll FI, Blackwell JT (1974) Optical isomers of aryl-2-piperidylmethanol antimalarial agents. Preparation, optical purity, and absolute stereochemistry. J Med Chem 17: 210–219
Cheng CC (1971) Structure and antimalarial activity of aminoalcohols and 2-(p-ehlorophenyl)-2-(4- piperidyl)tetrahydrofuran. J Pharm Sci 60: 1596–1598
Chevli R, Fitch CD (1981) The antimalarial drug, mefloquine, binds to normal erythrocyte mem-branes. Fed Proc 40: 776
Chien PL, Cheng CC (1973) Further side chain modification of antimalarial phenanthrene amino alcohols. J Med Chem 16: 1093–1096
Chien PL, Cheng CC (1976) Difference in antimalarial activity between certain amino alcohol dia- stereomers. J Med Chem 19: 170 - 172
Chou AC, Chevli R, Fitch CD (1980) Ferriprotoporphyrin IX fulfills the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry 19: 1543–1549
Clyde DF, McCarthy VC, Rebert CC, Miller RM (1973) Prophylactic activity of a phenanthrene methanol (WR 33063) and a quinoline methanol (WR 30090) in human malaria. Antimicrob Agents Chemother 3: 220–223
Clyde DF, McCarthy VC, Miller RM, Hornick RB (1976) Suppressive activity of mefloquine in sporozoite-induced human malaria. Antimicrob Agents Chemother 9: 384–386
Cohen A, King H (1938) Antimalarial action and chemical constitution. I. Cinchona alkaloidal derivatives and allied substances. Proc R Soc London Ser B 125: 49–60
Crawford CR, Lee C (1975) Intravenous toxicity of a-2-piperidyl-2,8-bis trifluoromethyl-4-quinoline-methanol methanesulfonate, WR 142,490, in dogs and monkeys. Fed Proc 34: 805
Davidson MW, Griggs BG Jr, Boykin DW, Wilson WD (1975) Mefloquine, a clinically useful quinolinemethanol antimalarial which does not significantly bind to DNA. Nature 254: 632–634
Davidson MW, Griggs BG Jr, Boykin DW, Wilson WD (1977) Molecular structural effects involved in the interaction of quinolinemethanolamines with DNA. Implications for antimalarial action. J Med Chem 20: 1117–1122
Davies EE, Warhurst DC, Peters W (1975) The chemotherapy of rodent malaria, XXI. Action of quinine and WR 122,455 (a 9-phenanthrenemethanol) on the fine structure of Plasmodium berghei in mouse blood. Ann Trop Med Parasitol 69: 147–153
Desjardins RE, Canfield CJ, Haynes JD, Chulay JD (1979 a) Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 16: 710–718
Desjardins RE, Pamplin CL III, von Bredow J, Barry KG, Canfield CJ (1979b) Kinetics of a new antimalarial, mefloquine. Clin Pharmacol Ther 26: 372–379
Doberstyn EF, Phintuyothin P, Noeypatimanondh S, Teerakiartkamjorn C (1979) Single dose therapy of falciparum malaria with mefloquine or pyrimethamine-sulfadoxine. Bull WHO 57: 275–279
Emery CE, Stancato FA, Brown RE, Prichard DA, Wolfe AD (1982) Arylmethanol and thiosemicar- bazone influence on plasmodial macromolecular synthesis and cell stability. Manuscript in preparation
Estensen RD, Krey AK, Hahn FE (1969) Studies on a deoxyribonucleic acid-quinine complex. Mol Pharmacol 5: 532–541
Feingold DS, HsuChen CC, Sud IJ (1974) Basis for the selectivity of action of the polymyxin antibiotics on the cell membranes. Ann NY Acad Sei 235: 480–492
Fitch CD (1969) Chloroquine resistance in malaria: a deficiency in chloroquine binding. Proc Natl Acad Sei USA 64: 1181–1187
Fitch CD (1972) Chloroquine resistance in malaria: drug binding and cross resistance patterns. Proc Helm Soc Wash 39: 265–271
Fitch CD, Chan RL, Chevli R (1979) Chloroquine resistance in malaria: accessibility of drug receptors of mefloquine. Antimicrob Agents Chemother 15: 258–262
Glew RH, Collins WE, Miller (1978) Selection of increased quinine resistance in Plasmodium falciparum in aotus monkeys. Am J Trop Med Hyg 27: 9–13
Grethe G, Mitt T (1978) Mefloquine: German Patent 2, 806, 909
Grindel JM, Tilton PF, Schaffer RD (1977) Quantitation of the antimalarial agent mefloquine in blood plasma and urine using high pressure liquid chromatography. J Pharm Sei 66: 834–837
Hickmann E, Oeser HG, Moebius L (1979) German Patent 2, 940, 443
Ison AE, Davis CM (1969) Photoxocity of quinolinemethanols and other drugs in mice and yeast. J Invest Dermatol 52: 193–198
Jauch R, Griesser E, Oesterhalt G (1980) Metabolism of Ro-21-5998 ( Mefloquine) in the rat. Arzneim Forsch 30: 60–67
Jearnpipatkul A, Panijpan B (1980) Molecular complexes of quinoline antimalarials with iron porphyrin components of protease digested methemoglobin. Chem Biol Interact 33: 83–90
Kazim M, Puri SK, Dutta GP (1979) Chemotherapeutic studies with mefloquine and selection of a mefloquine resistant strain of Plasmodium berghei. Indian J Med Res [Suppl] 70: 95–102
Konigk E, Mirtsch S, Putfarken B, Abdel-Rasoul S (1981) Plasmodium chabaudi infection of mice: effects of chloroquine and mefloquine. Inhibition of ornithine decarboxylase activity. Tropenmed Parasitol 32: 73–76
Korte DW Jr, Heiffer MH, Kintner LD, Lee CC (1978) Comparative acute and subacute toxicities of erythro-a-(2-piperidyl)-2,8-bis(trifluoromethyl)-4-quinoline methanol HCl, WR-142490-HC1, (mefloquine HCl) and its threo diastereoisomer, WR-177602-HC1, in dogs. Fed Proc 37: 248
Korte DW Jr, Heiffer MH, Hacker MP, Kintner LD, Hong CB, Lee CC (1979) Subchronic toxicity of the antimalarial drug mefloquine hydrochloride WR 142,490 in monkeys and dogs. Fed Proc 38: 680
Langreth SG (1977) Electron microscope cytochemistry of host parasite membrane interactions in malaria. Bull WHO 55: 171–178
Loew GH, Sahakian R (1977) Conformational studies of a family of related antimalarial phenanthrene amino alcohols. J Med Chem 20: 163–166
Martin DC, Arnold JD, Clyde DF, Al Ibrahim M, Carson PE, Rieckmann KH,, Willerson D Jr (1973) A quinoline methanol (WR 30,090) for treatment of acute malaria. Antimicrob Agents Chemother 3: 214–219
Mendenhall DW, Higuchi T, Sternson LA (1979) Analysis of hydrophobic amine antimalarials in biological fluids with plastic ion selective electrodes. J Pharm Sei 68: 746–750
Merkli B (1978) German Offen 2, 820, 991
Merkli B, Richie RW (1980) Studies on the resistance to single and combined antimalarials in the Plasmodium berghei mouse model. Acta Trop 37: 228–231
Merkli B, Richie R, Peters W (1980) The inhibitory effect of a drug combination on the development of mefloquine resistance in Plasmodium berghei. Ann Trop Med Parasitol 74: 1–9
Minor JL, Short RD, Heiffer MH, Lee CC (1976) Reproductive effects of mefloquine hydrochloride 119 in rats and mice. Pharmacologist 18: 171
Mu J, Israeli Z, Dayton P (1975) Studies on the disposition and metabolism of mefloquine HCl (WR 142,490), a quinolinemethanol antimalarial, in the rat. Drug Metab Dispos 3: 198–210
Nakagawa T, Higuchi T, Haslam JL, Schaffer RD, Mendenhall D (1979) Gas liquid chromatography determination of whole blood antimalarial concentrations. J Pharm Sei 68: 718–721
Ohnmacht CJ, Patel AR, Lutz RE (1971) Antimalarials. 7. Bis(trifluoromethyl)-a-(2-piperidyl)-4-quinolinemethanols. J Med Chem 14: 926–928
Oijih AV, Banyal HS, Chevli R, Fitch CD (1981) Hemin lyses malaria parasites. Science 214: 667–669
Peters W, Porter M (1976) The chemotherapy of rodent malaria, XXVI. The potential value of WR 122,455 (a 9-phenanthrenemethanol) against drug-resistant malaria parasites. Ann Trop Med Parasitol 70: 271–281
Peters W, Howells RE, Portus J, Robinson BL, Thomas S, Warhurst DC (1977 a) The chemotherapy of rodent malaria, XXVII. Studies on mefloquine (WR 142,490). Ann Trop Med Parasitol 71: 407–418
Peters W, Portus J, Robinson BL (1977 b) The chemotherapy of rodent malaria, XXXVIII. The development of resistance to mefloquine (WR 142,490). Ann Trop Med Parasitol 71: 419–427
Peters W, Trotter ER, Robinson BL (1980) The experimental chemotherapy of leishmaniasis. VII. Drug responses of Leishmania major, and Leishmania mexicana amazonensis with an analysis of promising leads to new antileishmanial agents. Ann Trop Med Parasitol 74: 321–336
Porter M, Peters W (1976) The chemotherapy of rodent malaria, XXV. Antimalarial activity of WR 122,455 (a 9-phenanthrenemethanol) in vivo and in vitro. Ann Trop Med Parasitol 70: 259–279
Research Reports, Walter Reed Army Inst Res Vols 2–3 (1981)
Rieckmann KH, Trenholme GM, Wilhams RL, Carson PE, Frischer H, Desjardins RE (1974) Prophylactic activity of mefloquine hydrochloride WR 142,490 in drug resistant malaria. Bull WHO 51: 375–378
Rothe WE, Jacobus DP (1968) Laboratory evaluation of the phototoxic potency of quinolinemethanols. J Med Chem 11: 366–368
Rozman RS, Molek NA, Koby R (1978) The absorption, distribution, and excretion in mice of the antimalarial mefloquine, erythro-2,8-bis(trifluoromethyl)-la-(2-piperidyl)-4-quinolinemethanol hydrochloride. Drug Metab Dispos 6: 654–658
Schmidt LH, Crosby R, Rasco J, Vaughn D (1978 a) Antimalarial activities of various 4-quinoline- methanols with special attention to WR-142,490 (mefloquine). Antimicrob Agents Chemother 13: 1011–1030
Schmidt LH, Crosby R, Rasco J, Vaughn D (1978 b) Antimalarial activities of the 4-quinolinemethanols WR-184,806 and WR-226,253. Antimicrob Agents Chemother 14: 680–689
Schupbach ME (1979) Mutagenicity evaluation of the 2 antimalarial agents chloroquine and mefloquine using a bacterial fluctuation test. Mutat Res 68: 41–50
Schwartz DE (1980) Quantitative determination of the antimalarial drug mefloquine and its main metabolite in plasma by direct densitometric measurement on thin-layer chromatographic plates. Anal Chem Symp Ser 3: 69–74
Schwartz DE, Weber W, Richard-Lenoble D, Gentilini M (1980) Kinetic studies of mefloquine and one of its metabolites, Ro 21–5104, in the dog and in man. Acta Trop 37: 238–242
Storm DR, Rosenthal KS, Swanson PE (1977) Polymyxin and related peptide antibiotics. Annu Rev Biochem 46: 723–763
Strube RE (1975) The search for new antimalarial drugs. J Trop Med Hyg 78: 171–185
Sweeney TR (1981) The present status of malaria chemotherapy: Mefloquine, a novel antimalarial. Med Res Rev 1: 281 - 301
Thong YH, Ferrante A, Rowan-Kelly B, O Keefe DE (1979) Effect of mefloquine on the immune response in mice. Trans R Soc Trop Med Hyg 73: 388–390
Trenholme GM, Williams RL, Desjardins RE, Frischer H, Carson PE, Rieckmann KH (1975) Mefloquine (WR 142,490) in the treatment of human malaria. Science 190: 792–794
Warhurst DC, Homewood CA, Peters W, Baggaley VC (1972) Pigment changes in Plasmodium berghei as indicators of activity and mode of action of antimalarial drugs. Proc Helm Soc Wash 39: 271–278
Wolfe AD (1979) The influence of mefloquine on Escherichia coli AT-9. Abstr 79th Annu Meet ASM 15120
Yanko WH, Deebel GF (1980) Carbon-14-labelled antimalarials. I. Synthesis of dl-erythro- and threo-a-2-piperidyl)-2,8-bis(trifluoromethyl)-4-quinohnemethanol-a-14C. J. Labelled Compd Ra- diopharm 17: 431–437
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Wolfe, A.D. (1983). Mefloquine. In: Hahn, F.E. (eds) Modes and Mechanisms of Microbial Growth Inhibitors. Antibiotics, vol 6. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68946-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-68946-8_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-68948-2
Online ISBN: 978-3-642-68946-8
eBook Packages: Springer Book Archive